CYTOKINETICS, INCORPORATED Amortization of Debt Discount (Premium)
CYTOKINETICS, INCORPORATED (CYTK) reported Amortization of Debt Discount (Premium) of $200.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2020-03-04
- CYTOKINETICS, INCORPORATED amortization of debt discount (premium) for fiscal 2019 was $200.00K.
- CYTOKINETICS, INCORPORATED amortization of debt discount (premium) for fiscal 2015 was $3.00K.
- CYTOKINETICS, INCORPORATED amortization of debt discount (premium) for fiscal 2014 was $0.00.
- CYTOKINETICS, INCORPORATED amortization of debt discount (premium) for fiscal 2013 was $0.00.
| Period end | Amortization of Debt Discount (Premium) 12 month |
|---|---|
| 2019-12-31 | $200.00K 10-K · filed 2020-03-04 |
| 2015-12-31 | $3.00K 10-K · filed 2016-03-03 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-03 |
| 2013-12-31 | $0.00 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |